Brief: Race Oncology Executes A$8.6M Contract
05/03/2025 01:16
March 5 (Reuters) - Race Oncology Ltd RAC.AX: RACE EXECUTES A$8.6M CONTRACT TO SUPPORT PHASE 1 TRIAL OF RC220 IN SOLID TUMOUR PATIENTS Further company coverage: RAC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220